We are thrilled to announce that the Rheumatology Society of Ghana (RSG), in partnership with the African League Against Rheumatism ( AFLAR ), will officially host the AFLAR 2027 Congress in the vibrant city of Accra. Under the inspiring theme "Innovate, Integrate, Impact: Shaping the Future of Rheumatology in Africa," this premier continental meeting marks a historic milestone for the Ghanaian medical community and the broader West African healthcare landscape. AFLAR 2027 is designed to be a transformative experience for the 500 to 800+ delegates expected to arrive from across the globe. The three-day scientific programme is meticulously structured to address the unique challenges and opportunities within African healthcare: Day 1: Innovate – Highlighting cutting-edge research, new diagnostic technologies, and the latest pharmaceutical advancements in autoimmune care. Day 2: Integrate – Focusing on multidisciplinary care models, bridging the gap between primary care and specialists, and strengthening healthcare infrastructure. Day 3: Impact – Dedicated to translating science into improved patient outcomes, public policy changes, and sustainable access to care. The significance of hosting this event in Ghana cannot be overstated. It provides a rare localized platform for our domestic healthcare workers to engage with international standards of care while showcasing the resilience and ingenuity of African clinical practice. By bringing the global rheumatology community to our doorstep, we are fostering a spirit of collaboration that will outlast the three-day event. This congress serves as a catalyst for future research partnerships and provides a global stage for our local researchers to present findings that are specifically relevant to our unique genetic and environmental landscape. Accra, known for its warm hospitality, rich cultural heritage, and modern amenities, serves as the perfect backdrop for this exchange of knowledge. We invite you to join us in shaping the future of African rheumatology. Beyond the lecture halls, the congress will offer cultural tours and gala events designed to strengthen the bonds between delegates. Keep an eye on our Communications hub for upcoming details regarding abstract submission portals, early-bird registration, and partnership packages. Together, let us innovate for a healthier Africa.
As the Rheumatology Society of Ghana (RSG) continues to expand its reach, it is essential to address the broader systemic challenges that impact the delivery of care for rheumatic and musculoskeletal diseases (RMDs) across our nation. While our clinical expertise is growing, the path to comprehensive care for the average Ghanaian patient remains hindered by several "general issues" that require urgent attention from policymakers, healthcare administrators, and the public alike. One of the most pressing concerns is the high cost of long-term care. Rheumatic conditions are, by definition, chronic. Unlike an acute infection that can be cleared with a single course of antibiotics, conditions like Rheumatoid Arthritis or Psoriatic Arthritis require life-long medication and monitoring. For many in our community, the financial burden of monthly prescriptions, frequent laboratory tests, and specialized imaging like musculoskeletal ultrasounds is overwhelming. When these costs are not fully covered by insurance, patients are often forced to choose between their health and their daily livelihood, leading to "medical non-compliance" that isn't a choice, but a financial necessity. Furthermore, there is a significant geographical disparity in access to specialized care. Currently, the majority of Ghana’s rheumatology resources are concentrated in major urban hubs like Accra and Kumasi. For a patient living in the northern regions or rural outskirts, a single follow-up appointment can involve a full day of travel and significant transportation costs. This "distance barrier" often leads to lost follow-ups, allowing manageable conditions to flare into debilitating crises. To address these hurdles, the RSG is advocating for a more integrated healthcare model. We are calling for: Wider Insurance Coverage : Incorporating more specialized DMARDs (Disease-Modifying Anti-Rheumatic Drugs) and diagnostic tests into the National Health Insurance Scheme. Telemedicine Initiatives : Leveraging digital health to provide remote consultations for stable patients in underserved areas. Primary Care Training : Equipping general practitioners and nurses across all ten regions with the skills to recognize early warning signs and manage basic maintenance therapy. The burden of RMDs is not just a medical issue; it is a socio-economic one. When a young breadwinner is sidelined by chronic pain, the entire family unit suffers. By addressing these systemic gaps, we aren't just treating joints—we are protecting the productivity and well-being of our nation. We invite our partners and stakeholders to explore our Advocacy page to see how we are working to make rheumatology care accessible to every Ghanaian, regardless of their location or income. Together, we can build a healthcare system that truly leaves no one behind.
Systemic Lupus Erythematosus (SLE), commonly known as Lupus, is often referred to as a "great imitator" because its symptoms mimic so many other illnesses. In Ghana, the burden of Lupus is significant, yet it remains one of the most misunderstood and underdiagnosed autoimmune conditions in the region. The Rheumatology Society of Ghana is committed to changing this narrative through increased clinical research and public awareness. Lupus predominantly affects women of childbearing age, and research suggests that patients of African descent often experience more severe disease manifestations and complications, such as Lupus Nephritis (kidney involvement). Unfortunately, the journey to a diagnosis in Ghana can be long and fraught with frustration. Many patients rotate through several clinics for years, treating symptoms like joint pain, skin rashes, and extreme fatigue as isolated issues before finally being referred to a rheumatologist. This delay is often where the most damage occurs, as untreated inflammation can lead to permanent organ failure or severe cardiovascular events. The "treatment gap" remains a primary challenge. While standard therapies like hydroxychloroquine are generally accessible, advanced treatments such as biologics remain prohibitively expensive for many. Furthermore, the psychological toll of living with a chronic, invisible illness can be devastating. Many patients face social stigma or are misunderstood by their families because they "look healthy" while struggling with debilitating internal pain. This is why the RSG works closely with patient advocacy groups to provide not just medical care, but a support system that addresses the holistic needs of the patient, including mental health resources and peer support groups. Our Research and Advocacy pages contain updated information on how we are working with the Ministry of Health to improve the availability of diagnostic tests and essential medications. We are actively pushing for the inclusion of specialized immunological tests under the National Health Insurance Scheme (NHIS) to ensure that financial status does not dictate survival. We believe that by educating primary care physicians to recognize the "butterfly rash" and other early markers, we can catch the disease before it causes irreversible organ damage. Stay tuned to our Communications section for upcoming patient education webinars and specialist insights into managing Lupus in the Ghanaian context.